8-K filed November 3, 2021, 7:59 PM ET ticker BFRI CIK 0001858685

other material confidence high sentiment positive materiality 0.80

Biofrontera completes $18M IPO on Nasdaq; net proceeds $15.4M, board expanded with independent directors

Biofrontera Inc.

IPO of 3.6M units at $5.00/unit (1 share + 1 warrant) closed Nov 2, 2021; gross proceeds $18M, net ~$15.4M.
Underwriters exercised full over-allotment for additional 540,000 warrants; warrants have $5.00 exercise price, 5-year term.
Common stock and warrants trade on Nasdaq Capital Market under symbols BFRI and BFRIW.
Board changes: Erica Monaco resigned; John Borer, Beth Hoffman, and Loretta Wedge appointed; Hoffman and Wedge independent.
New directors appointed to audit, nominating, and compensation committees.

item 1.01 item 5.02 item 5.03 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John J. Borer

Director

BFRI · Biofrontera Inc.

Effective: 2021-11-02
Filed: November 3, 2021, 7:59 PM ET

John J. Borer, Beth J. Hoffman, Ph.D, and Loretta M. Wedge, CPA, CCGMA (collectively, the “Directors”) were appointed to the board of directors of the Company

Appointed

Loretta M. Wedge

Director

BFRI · Biofrontera Inc.

Effective: 2021-11-02
Filed: November 3, 2021, 7:59 PM ET

John J. Borer, Beth J. Hoffman, Ph.D, and Loretta M. Wedge, CPA, CCGMA (collectively, the “Directors”) were appointed to the board of directors of the Company

Departed

Erica Monaco

Director

BFRI · Biofrontera Inc.

Effective: 2021-11-02
Filed: November 3, 2021, 7:59 PM ET

Erica Monaco resigned her position on the board of directors of the Company

Appointed

Beth J. Hoffman

Director

BFRI · Biofrontera Inc.

Effective: 2021-11-02
Filed: November 3, 2021, 7:59 PM ET

John J. Borer, Beth J. Hoffman, Ph.D, and Loretta M. Wedge, CPA, CCGMA (collectively, the “Directors”) were appointed to the board of directors of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John J. Borer was appointed as Director at Biofrontera Inc..

Action: appointed
Role: Director

Exact text from the filing

John J. Borer, Beth J. Hoffman, Ph.D, and Loretta M. Wedge, CPA, CCGMA (collectively, the “Directors”) were appointed to the board of directors of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Loretta M. Wedge was appointed as Director at Biofrontera Inc..

Action: appointed
Role: Director

Exact text from the filing

John J. Borer, Beth J. Hoffman, Ph.D, and Loretta M. Wedge, CPA, CCGMA (collectively, the “Directors”) were appointed to the board of directors of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Erica Monaco resigned as Director at Biofrontera Inc..

Action: resigned
Role: Director

Exact text from the filing

Erica Monaco resigned her position on the board of directors of the Company

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Beth J. Hoffman was appointed as Director at Biofrontera Inc..

Action: appointed
Role: Director

Exact text from the filing

John J. Borer, Beth J. Hoffman, Ph.D, and Loretta M. Wedge, CPA, CCGMA (collectively, the “Directors”) were appointed to the board of directors of the Company

View on SEC.gov

Biofrontera Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-027052

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.